The acquisition of Nautilus and continued investment by Croda to establish the new Centre of Innovation for Marine Biotechnology in PEI, will accelerate the company’s research and product development program to identify sustainable, natural sources of functional ingredients for a broad range of personal, health and crop care ingredients for its global customers.
“Croda is a company that values innovation and invests in new technologies to deliver value to our customers today and in the future,” said Sandra Breene, president, personal care, Croda International. “The acquisition of Nautilus is part of our journey to expand from being a manufacturer of specialty chemicals into an organization that embraces biotechnology as the answer to many of our customers and the consumer needs for new actives in a truly sustainable way.”
The opening of the expanded Nautilus site follows the investment by Croda in an automated high-throughput screening system that can dramatically increase the discovery of novel products derived from the marine microbe library.
Dr. Russ Kerr, Canada research chair in marine natural products at UPEI, and founder of Nautilus Biosciences, has worked since 2007 to establish the Marine Microbial Library at UPEI, collecting marine samples from the oceans of Canada and around the world and developing techniques to assess their value.
“This is an exciting day for us,” said Kerr. “We’ve been very fortunate to build on a relationship with a multinational specialty chemical company that values growth through sustainable innovation–enhancing our ability to discover even more marine microbes as a potential source of commercial ingredients. We are very proud to be opening this Centre of Innovation in Marine Biotechnology in Prince Edward Island.”